PMD(Delisted)
Psychemedics·NASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About PMD
Psychemedics Corporation
The world’s largest provider of hair testing for drugs of abuse
5220 Spring Valley Road, Dallas, Texas 75254
--
Psychemedics Corporation is a Delaware corporation established on September 24, 1986 to provide testing services for the detection of substances of abuse through the analysis of hair samples. The company's test method uses proprietary technology, enzymes to dissolve the hair sample, and then the sampled hair is radioimmunoassayed by mass spectroscopy. The company's main proprietary technology as a testing service is to analyze hair samples for the abuse of certain drugs. The radioimmunoassay procedure used on drug-tested hair samples is different from the more commonly used method for the immunoassay procedure used to detect urine samples. The company's tests provide quantitative information that can indicate the approximate amount of drug intake, as well as historical data that can show an individual's pattern of drug use over an extended period of time, providing high-quality detection relative to other types of drug testing. This information is useful for applicant and employee testing, as well as for physicians, treatment professionals, law enforcement agencies, and school administrators. Parents are concerned about their children's medications and the use of medications or potential use of medications by individuals and entities. The company provides commercial testing and confirmation using industry recognized practices: cocaine, cannabis, pentachlorophenol, methamphetamine and opiates.
Company Financials
EPS
PMD has released its 2024 Q1 earnings. EPS was reported at -0.12, versus the expected 0, missing expectations. The chart below visualizes how PMD has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
PMD has released its 2024 Q3 earnings report, with revenue of 5.17M, reflecting a YoY change of -9.27%, and net profit of -535.00K, showing a YoY change of 74.51%. The Sankey diagram below clearly presents PMD's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
